Tissue engineering

Organ-on-Chip Market Analysis Report 2024-2033: Rising Adoption of OOC Technology among Pharmaceutical and Biotechnology Companies - ResearchAndMarkets.com

Retrieved on: 
Donnerstag, Juni 13, 2024
Biotechnology, Pharmaceutical, Health, Research, Drug discovery, Microfluidics, Cell biology, Region, Growth, Tissue engineering, OOC, Partnership, Investment, Drug development, Country, Government, Pharmaceutical industry

The "Organ-on-Chip Market - A Global and Regional Analysis: Focus on Offering, Organ Type, Application, End User, and Country - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Organ-on-Chip Market - A Global and Regional Analysis: Focus on Offering, Organ Type, Application, End User, and Country - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.
  • Application: Drug Discovery Segment to Continue Dominating the Organ-on-Chip Market - Organ-on-chip market has been led by drug discovery, which held a 65.20% share in 2023.
  • Offering: Product Segment to Continue Dominating the Organ-on-Chip Market - The organ-on-chip market has been led by product, which held a 53.94% share in 2023.
  • Organ Type: Liver-on-a-Chip Segment to Continue Dominating the Organ-on-Chip Market - Organ-on-chip market has been led by liver-on-a-chip, which held a 28.31% share in 2023.

$318.8 Mn Dural Adhesive Agent for Surgical Market - Global and Regional Analysis and Forecasts, 2024-2034 Featuring Prominent Players - Integra LifeSciences, Covidien, Baxter, Johnson & Johnson - ResearchAndMarkets.com

Retrieved on: 
Donnerstag, Juni 6, 2024
Surgery, Health, Medical Supplies, Brain damage, Prevalence, Epilepsy, Region, Growth, Ageing, Benchmarking, Tissue engineering, MIS, DSM-IV codes, Brain, DTA, Neurosurgery, Gel, Tetraplegia, Science Translational Medicine, Adhesive

Key Questions Answered in this Report:

Key Points: 
  • Key Questions Answered in this Report:
    What are the main factors driving the demand for dural adhesive agent for surgical market?
  • Who are the key players in the dural adhesive agent for surgical market, and what are their respective market shares?
  • What is the current estimation of the dural adhesive agent for surgical market, and what growth trajectory is projected from 2024 to 2034?
  • Which regions demonstrate the highest adoption rates for dural adhesive agent for surgical market, and what factors contribute to their leadership?

Prolific Machines to Harness Light to Deliver Unprecedented Cellular Control, Enabling Higher Quality and Never-Before-Possible Biosolutions — Beginning a New Era of Biotechnology

Retrieved on: 
Donnerstag, Juni 6, 2024
Biotechnology, Pharmaceutical, Hardware, General Health, Health, Engineering, Technology, Manufacturing, Cell, Multimedia, San Francisco Bay Area, Vaccine, Research, Breakthrough Energy, Infant, Doctor of Philosophy, Environmental health, Tissue engineering, Fonterra, Partnership, Fermentation, AI, Medicine, CIO, Food, Light, Biology, College of Engineering (KNUST), IQT, Antibody, SOSV

View the full release here: https://www.businesswire.com/news/home/20240606065697/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240606065697/en/
    Prolific Machines unlocks unprecedented cellular control using light to produce everyday essentials more efficiently, from food and lifesaving drugs to novel biosolutions.
  • Inspired by the burgeoning field of optogenetics, Prolific Machines’ novel approach uses light to more efficiently and effectively control biology.
  • We have only scratched the surface of what’s possible with our technology,” said Prolific Machines Co-Founder and CEO, Deniz Kent, PhD.
  • Visit prolific-machines.com to learn more, and contact [email protected] to inquire about co-developing the future of biology with Prolific Machines.

Kirigami hydrogels rise from cellulose film

Retrieved on: 
Freitag, April 12, 2024
Science, Nanofiber, Gel, University of Tokyo, Swelling, Administration, Hydrogel, Research, Kirigami, Water, The Journal, Cellulose, Tissue engineering, Movement, Growth, Advanced Materials

Their work extends the emerging field of 'kirigami hydrogels', in which patterns are cut into a thin film allowing it to later swell into complex hydrogel structures.

Key Points: 
  • Their work extends the emerging field of 'kirigami hydrogels', in which patterns are cut into a thin film allowing it to later swell into complex hydrogel structures.
  • Researchers Daisuke Nakagawa and Itsuo Hanasaki worked with an initially dry film composed of nanofibers of cellulose, the natural material that forms much of the structure of plant cell walls.
  • They used laser processing to cut structures into the film before water was added allowing the film to swell.
  • The advance in kirigami hydrogels achieved by the TUAT team significantly extends the options for future hydrogel applications.

Induced Pluripotent Stem Cell (iPSC) Industry Market Size, Trends, and Forecast Report - ResearchAndMarkets.com

Retrieved on: 
Dienstag, Mai 7, 2024
Health, Stem Cells, OA, Cellular Dynamics International, University, Microsoft Exchange Server, Cell, CRISPR, Safety, Drug development, Osteoarthritis, World Games, MSC, Partnership, Research, CLI, B cell, Application, Disease, Human, Therapy, Patient, COVID-19, Tissue engineering, Graft-versus-host disease, IPSC, Medicine, Kyoto University, 3D bioprinting, Macular degeneration, Regenerative medicine, CDI, Clinical trial, Toxicology, Drug discovery, Personalized medicine, Merck, Thermo Fisher Scientific, Pharmaceutical industry

The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • Since the discovery of induced pluripotent stem cell (iPSC) technology in 2006, significant progress has been made in stem cell biology and regenerative medicine.
  • Today, methods of commercializing induced pluripotent stem cells (iPSCs) include:
    Cellular Therapy: iPSCs are being explored in a diverse range of cell therapy applications for the purpose of reversing injury or disease.
  • This global strategic report reveals all major market competitors worldwide, including their core technologies, strategic partnerships, and products under development.

CytoHub Bolsters Team with Top Industry Experts to Enhance Leadership in Cell Therapy and Regenerative Medicine Innovation

Retrieved on: 
Montag, Mai 6, 2024
Biotechnology, Health, Pharmaceutical, Technology, Artificial Intelligence, Cloud, Cell, Biomedical engineering, MSU, Artificial intelligence, Biomedicine, Machine learning, Tissue engineering, IPSC, Lead, Regenerative medicine, Biology, GMP, Associate, Technical, Medical device

CytoHub, Inc. , a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.

Key Points: 
  • CytoHub, Inc. , a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.
  • These appointments mark a significant enhancement of CytoHub’s leadership, aligning with the company’s commitment to advancing biomanufacturing innovations in cell therapy and regenerative medicine.
  • David DiGiusto, Ph.D., brings over three decades of experience in translational medicine and GMP compliant iPSC derived cells as therapeutics agents and biologics manufacturing.
  • CytoHub is at the forefront of this industrialized biology, driving cell therapy and regenerative medicine innovations.

Nanofibers Industry Poised for Exponential Growth: 26% CAGR Anticipated from 2023 to 2028

Retrieved on: 
Donnerstag, Mai 2, 2024
Ceramic, Nanofiber, Filtration, Investment, Glass, Key market, Metal, International finance, Transport, Semiconductor, Carbon, Food industry, Polymer, Tissue engineering, Electronics, Regenerative medicine, Alloy, Growth, Row

BOSTON, May 2, 2024 /PRNewswire/ -- According to the latest BCC Research study, the demand for Global Markets and Technologies for Nanofibers is growing from $2.9 billion in 2023 to $9.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.0% from 2023 through 2028."

Key Points: 
  • Applications: Nanofibers find diverse uses across industries, from life sciences to transportation, contributing to advancements in tissue engineering, filtration, energy storage, electronics, and sensing technologies.
  • Regions: The global nanofiber market sees significant activity in North America, Europe, Asia-Pacific, and emerging markets worldwide, driving innovation and adoption.
  • The global market for nanofibers is projected to grow from $2.4 billion in 2022 to $9.4 billion in 2028 at a compound annual growth rate (CAGR) of 26.0% during the forecast period.
  • The key factors driving the growth of the nanofibers market include:
    Advances in the life science sector.

Global Functional Dyspepsia Drug Market to reach a valuation of US$ 16.4 billion by 2034, Future Market Insights, Inc. Projection

Retrieved on: 
Mittwoch, Mai 1, 2024
Gastroenterology, Transplant, Acupuncture, Indigestion, Research, Laboratory, Probiotic, Abbott Laboratories, Herbal, Therapy, Patient, Tissue engineering, Enzyme inhibitor, Regenerative medicine, Collaboration, Market, Diagnosis, Antacid, Drug development, Regeneration, Ageing, Investment, Nutritional science, Pharmaceutical industry

NEWARK, Del., May 1, 2024 /PRNewswire/ -- The global functional dyspepsia drug market will reach a valuation of US$ 10.3 billion in 2024, attributed to factors such as increasing geriatric population. The trend is set to create new opportunities for the market, leading to a projected CAGR of 4.8% between 2024 and 2034, and reaching a total valuation of approximately US$ 16.4 billion by 2034.

Key Points: 
  • NEWARK, Del., May 1, 2024 /PRNewswire/ -- The global functional dyspepsia drug market will reach a valuation of US$ 10.3 billion in 2024, attributed to factors such as increasing geriatric population.
  • Collaboration between pharmaceutical companies, academic institutions, and research organizations fosters innovation in functional dyspepsia drug development.
  • Key Takeaways from the Market Study:
    Global functional dyspepsia drug market was valued at US$ 9.7 billion in 2023.
  • The functional dyspepsia drug market is characterized by a diverse array of pharmaceutical companies, research institutions, and healthcare organizations striving to develop and commercialize innovative treatments for functional dyspepsia.

Global Functional Dyspepsia Drug Market to reach a valuation of US$ 16.4 billion by 2034, Future Market Insights, Inc. Projection

Retrieved on: 
Mittwoch, Mai 1, 2024
Gastroenterology, Transplant, Acupuncture, Indigestion, Research, Laboratory, Probiotic, Abbott Laboratories, Herbal, Therapy, Patient, Tissue engineering, Enzyme inhibitor, Regenerative medicine, Collaboration, Market, Diagnosis, Antacid, Drug development, Regeneration, Ageing, Investment, Nutritional science, Pharmaceutical industry

NEWARK, Del., May 1, 2024 /PRNewswire/ -- The global functional dyspepsia drug market will reach a valuation of US$ 10.3 billion in 2024, attributed to factors such as increasing geriatric population. The trend is set to create new opportunities for the market, leading to a projected CAGR of 4.8% between 2024 and 2034, and reaching a total valuation of approximately US$ 16.4 billion by 2034.

Key Points: 
  • NEWARK, Del., May 1, 2024 /PRNewswire/ -- The global functional dyspepsia drug market will reach a valuation of US$ 10.3 billion in 2024, attributed to factors such as increasing geriatric population.
  • Collaboration between pharmaceutical companies, academic institutions, and research organizations fosters innovation in functional dyspepsia drug development.
  • Key Takeaways from the Market Study:
    Global functional dyspepsia drug market was valued at US$ 9.7 billion in 2023.
  • The functional dyspepsia drug market is characterized by a diverse array of pharmaceutical companies, research institutions, and healthcare organizations striving to develop and commercialize innovative treatments for functional dyspepsia.

Feinstein Institutes’ Daniel A. Grande Named President-Elect of the International Cartilage Regeneration & Joint Preservation Society (ICRS)

Retrieved on: 
Donnerstag, April 18, 2024
Health, Hospitals, Other Health, Other Science, General Health, Research, Science, Education, FDA, Rheumatology, EVS, Microsoft Exchange Server, Intervertebral disc, Regenerative medicine, Seminal vesicles, Cartilage, Doctor of Philosophy, B cell, Meniscus, ICRS, Patient, Tissue engineering, Molecular medicine, 3D bioprinting, Medical research, Microsoft Access, Multimedia, Regeneration, Stem cell, Credit, Journal, Medical device

The International Cartilage Regeneration & Joint Preservation Society (ICRS) has named Daniel A. Grande, PhD, assistant vice president of research services and professor of molecular medicine and orthopedic surgery at The Feinstein Institutes for Medical Research , its new President-Elect.

Key Points: 
  • The International Cartilage Regeneration & Joint Preservation Society (ICRS) has named Daniel A. Grande, PhD, assistant vice president of research services and professor of molecular medicine and orthopedic surgery at The Feinstein Institutes for Medical Research , its new President-Elect.
  • View the full release here: https://www.businesswire.com/news/home/20240418363701/en/
    Feinstein Institutes’ Dr. Daniel A. Grande has been named the new president-elect of International Cartilage Repair Society.
  • (Credit: Feinstein Institutes)
    Dr. Grande, renowned for his significant contributions to cartilage repair and regeneration, will lead the ICRS in its mission to advance science and education in preventing and treating cartilage injuries.
  • "I am honored and excited to serve as the President-Elect of the International Cartilage Regeneration & Joint Preservation Society.